STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Schedule 13G: Bandera Partners Holds 4.6% of Dyadic (DYAI)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bandera Partners LLC, together with Managing Members Gregory Bylinsky and Jefferson Gramm, filed an amended Schedule 13G reporting ownership of 1,383,308 shares of Dyadic International, Inc. common stock as of June 30, 2025. Those shares represent 4.6% of the outstanding class based on 30,090,661 shares reported by the issuer on May 13, 2025. The shares are directly held by Bandera Master Fund L.P.; Bandera Partners is the investment manager with authority to vote and dispose of the shares, and Messrs. Bylinsky and Gramm are reported as managing members with shared voting and dispositive power. The filing states the position is held in the ordinary course of business and not for control purposes.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Passive ownership disclosure of 4.6% via an investment manager; not a control stake.

The filing documents a non-control position where Bandera Master Fund holds 1,383,308 shares and Bandera Partners, as investment manager, exercises voting and dispositive authority. At 4.6% of the float, this is below the 5% threshold that typically attracts greater regulatory and market scrutiny. The statement that holdings are in the ordinary course of business suggests a passive investment posture rather than an activist intent. For investors, the filing provides transparency on a modest concentrated holder without indicating any change in corporate control or strategy.

TL;DR: Disclosure clarifies manager authority and beneficial ownership but signals no control attempt.

The Schedule 13G clarifies that Bandera Partners, as the investment manager, may be deemed to beneficially own the shares held by Bandera Master Fund, while the principals disclaim direct beneficial ownership of shares they do not own. The certification attests the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing control. From a governance perspective, this is a routine disclosure that improves shareholder transparency without indicating imminent governance actions or proposals by the reporting persons.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Bandera Partners LLC
Signature:/s/ Gregory Bylinsky
Name/Title:Gregory Bylinsky, Managing Member
Date:08/19/2025
Bylinsky Gregory
Signature:/s/ Gregory Bylinsky
Name/Title:Gregory Bylinsky
Date:08/19/2025
Gramm Jefferson
Signature:/s/ Jefferson Gramm
Name/Title:Jefferson Gramm
Date:08/19/2025

FAQ

What stake does Bandera Partners report in DYAI?

The reporting persons disclose 1,383,308 shares, representing 4.6% of Dyadic International's common stock based on 30,090,661 shares outstanding.

Who holds the shares reported in the Schedule 13G for DYAI?

The shares are directly held by Bandera Master Fund L.P., with Bandera Partners LLC as the investment manager and Messrs. Bylinsky and Gramm as managing members.

Does the filing indicate Bandera Partners seeks control of DYAI?

No. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

What voting and dispositive powers are reported?

Bandera Partners reports 1,383,308 shares of sole voting and sole dispositive power; Messrs. Bylinsky and Gramm report shared voting and dispositive power over the same amount.

What date is the ownership information as of?

Ownership is reported as of the close of business on June 30, 2025.
Dyadic Intl Inc Del

NASDAQ:DYAI

DYAI Rankings

DYAI Latest News

DYAI Latest SEC Filings

DYAI Stock Data

33.84M
27.05M
25.17%
13.88%
0.32%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
JUPITER